PTH and chronic kidney disease: In addition, both oral calcium carbonate administration and the other CKD-MBD-related factors (corrected calcium, phosphorus, and intact PTH use) were not associated with uremic nausea in the present logistic regression analysis, suggesting that VDRAs might have an action on uremic nausea that differs from regulation of calcium homeostasis and bone turnover.